These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31186095)

  • 1. [Idiopathic bone marrow oedema: Outcome of 3 cases treated with denosumab].
    Zaldibar Barinaga MB; Reoyo Díez JI
    Rehabilitacion (Madr); 2019; 53(2):126-130. PubMed ID: 31186095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab is effective in the treatment of bone marrow oedema syndrome.
    Rolvien T; Schmidt T; Butscheidt S; Amling M; Barvencik F
    Injury; 2017 Apr; 48(4):874-879. PubMed ID: 28242067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of bone marrow edema syndrome in the knee with denosumab. Case report].
    Geith T; Mutschler W; Berger F
    Unfallchirurg; 2015 Mar; 118(3):230-2. PubMed ID: 25783691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of intravenous iloprost therapy in patients with bone marrow oedema of the hip.
    Zippelius T; Perka C; Preininger B; Matziolis G; Strube P; Röhner E
    Acta Orthop Belg; 2018 Jun; 84(2):172-178. PubMed ID: 30462600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous bisphosphonates and vitamin D in the treatment of bone marrow oedema in professional athletes.
    Simon MJ; Barvencik F; Luttke M; Amling M; Mueller-Wohlfahrt HW; Ueblacker P
    Injury; 2014 Jun; 45(6):981-7. PubMed ID: 24552768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile transient bone marrow oedema of the foot associated with Vitamin D deficiency: A case study and an overview of pathogenesis and treatment.
    Kaspiris A; Savvidou OD; Chrronopoulos E; Vasiliadis E
    Foot (Edinb); 2019 Mar; 38():50-53. PubMed ID: 30639799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.
    Röhner E; Zippelius T; Steindl D; Fussi J; Perka C
    Eur J Orthop Surg Traumatol; 2014 Dec; 24(8):1609-16. PubMed ID: 24048706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost.
    Disch AC; Matziolis G; Perka C
    J Bone Joint Surg Br; 2005 Apr; 87(4):560-4. PubMed ID: 15795211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients.
    Tang M; Xue L; Shen Y; Bo L; Yang R; Wen J; Zhang Y; Liu Z; Fu J
    Clin Rheumatol; 2018 Jan; 37(1):245-250. PubMed ID: 28497237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Effects of Intravenous Iloprost Therapy in Patients with Bone Marrow Oedema of the Knee Joint.
    Zippelius T; Matziolis G; Perka C; Putzier M; Strube P; Röhner E
    Acta Chir Orthop Traumatol Cech; 2018; 85(1):17-21. PubMed ID: 30257764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Bone Marrow Edema of the Foot and Ankle With the Prostacyclin Analog Iloprost.
    Hörterer H; Baumbach SF; Gregersen J; Kriegelstein S; Gottschalk O; Szeimies U; Walther M
    Foot Ankle Int; 2018 Oct; 39(10):1183-1191. PubMed ID: 29862844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain control with ibandronate for bone marrow oedema of the knee.
    Küchler L; Fehr T; Jeker R
    Swiss Med Wkly; 2020 Nov; 150():w20384. PubMed ID: 33246342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile bone-marrow oedema of the acetabulum treated by iloprost.
    Aigner N; Petje G; Schneider W; Krasny C; Grill F; Landsiedl F
    J Bone Joint Surg Br; 2002 Sep; 84(7):1050-2. PubMed ID: 12358371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient bone marrow oedema syndrome: a report of two cases.
    Bilgici A; Sakarya S; Bekir Selçuk M; Sakarya O
    Hip Int; 2010; 20(3):335-7. PubMed ID: 20640993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.
    Jäger M; Tillmann FP; Thornhill TS; Mahmoudi M; Blondin D; Hetzel GR; Zilkens C; Krauspe R
    Arthritis Res Ther; 2008; 10(5):R120. PubMed ID: 18834533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method.
    Aigner N; Petje G; Steinboeck G; Schneider W; Krasny C; Landsiedl F
    J Bone Joint Surg Br; 2001 Aug; 83(6):855-8. PubMed ID: 11521928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients.
    Mayerhoefer ME; Kramer J; Breitenseher MJ; Norden C; Vakil-Adli A; Hofmann S; Meizer R; Siedentop H; Landsiedl F; Aigner N
    Rheumatology (Oxford); 2007 Sep; 46(9):1460-5. PubMed ID: 17636179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab in bone marrow oedema syndrome.
    Grøvle L; Haugen AJ
    Injury; 2017 Jun; 48(6):1275-1276. PubMed ID: 28431819
    [No Abstract]   [Full Text] [Related]  

  • 19. Dimethyl fumarate-associated transient bone marrow oedema syndrome.
    Triplett J; Vijayan S; Prince R; Kermode A
    Mult Scler; 2019 May; 25(6):876-879. PubMed ID: 30051766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab in bone marrow oedema syndrome. Response to Letter to the Editor of Injury.
    Rolvien T; Schmidt T; Barvencik F; Amling M
    Injury; 2017 Oct; 48(10):2368. PubMed ID: 28784253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.